- Health: Does ibuprofen worsen the prognosis of coronavirus infection?
- Covid-19 The WHO concludes that anti-inflammatories such as ibuprofen do not provide benefits or risks to patients with coronavirus
A multidisciplinary team made up of scientists from London's Guy's and St Thomas' Hospital , Kings College and the pharmaceutical company SEEK Group are investigating whether ibuprofen, as an anti-inflammatory and pain reliever, could be used to treat the respiratory difficulties of patients affected by coronavirus.
In the trial, which has been baptized with the name Liberate , half of the patients will receive this medicine as a complement to the usual treatment.
The researchers hope that thanks to ibuprofen many patients can improve their lung insufficiencies without the need to be treated with respirators, as has already been successfully tested with animals.
The study will not use ibuprofen that anyone can buy at a pharmacy, but a special formulation that is already used for specific conditions, such as arthritis.
Liberate is being led by Professor Richard Beale , an intensive care specialist at Guy's and St Thomas Hospital, who admits that "treatment options for Covid-19 patients are limited" although with this trial they hope to find a "benefit" for these sick.
The use of ibuprofen generated enormous controversy at the beginning of the pandemic, especially after the publication by the French Minister of Health, Olivier Verán , of a tweet in which he pointed out that this drug could aggravate the infection caused by the coronavirus in people.
Subsequently, the World Health Organization (WHO) published a study in which it concluded that non-steroidal anti-inflammatory drugs, including ibuprofen, provide neither benefits nor risks to patients with Covid-19.
In accordance with the criteria of The Trust Project
Know more